Department of Surgery, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Cardiovascular Fellowship, Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Cardiovasc Hematol Disord Drug Targets. 2024;24(1):47-58. doi: 10.2174/011871529X298791240607041246.
Gallstone disease (GD) is increasing in the world and has various complications.
This study aims to examine the relationship between GD and the risk of mortality from cardiovascular disease (CVD) and cancer using a systematic review and meta-analysis approach.
A comprehensive and systematic search was done in various databases, such as Web of Science (WOS), Scopus, MEDLINE/PubMed, Cochrane, and Embase. The search included studies published from 1980 to December 2023. Heterogeneity was assessed using Chi-square, I2, and forest plots, while publication bias was evaluated through Begg's and Egger's tests. All analyses were performed using Stata 15, with statistical significance set at p <0.05.
A pooled analysis of five studies involving 161,671 participants demonstrated that individuals with GD had a significantly higher risk of mortality from CVD (RR 1.29, 95% CI: 1.11-1.50, p <0.001). Importantly, no evidence of publication bias was found based on the results of Begg's test (p =0.806) and Egger's test (p =0.138). Furthermore, the pooled analysis of seven studies, encompassing a total of 562,625 participants, indicated an increased risk of cancer mortality among individuals with GD (RR 1.45, 95% CI: 1.16-1.82, p <0.001). Similarly, no publication bias was detected through Begg's test (p =0.133) and Egger's test (p =0.089).
In this study, the evidence of a significant association between GD and an elevated risk of mortality from CVD and canceris provided. These findings suggest that implementing targeted interventions for individuals with gallstone disease could reduce mortality rates among these patients.
胆石病(GD)在全球范围内呈上升趋势,并伴有多种并发症。
本研究旨在通过系统评价和荟萃分析方法,探讨 GD 与心血管疾病(CVD)和癌症死亡风险之间的关系。
全面系统地检索了 Web of Science(WOS)、Scopus、MEDLINE/PubMed、Cochrane 和 Embase 等多个数据库中的研究,检索时间截至 2023 年 12 月。使用 Chi-square、I2 和森林图评估异质性,使用 Begg 和 Egger 检验评估发表偏倚。所有分析均使用 Stata 15 进行,统计显著性设为 p<0.05。
对 5 项包含 161671 名参与者的研究进行汇总分析显示,GD 患者 CVD 死亡风险显著升高(RR 1.29,95%CI:1.11-1.50,p<0.001)。重要的是,Begg 检验(p=0.806)和 Egger 检验(p=0.138)均未发现发表偏倚的证据。此外,对 7 项包含 562625 名参与者的研究进行汇总分析显示,GD 患者癌症死亡风险增加(RR 1.45,95%CI:1.16-1.82,p<0.001)。同样,Begg 检验(p=0.133)和 Egger 检验(p=0.089)均未发现发表偏倚的证据。
本研究提供了 GD 与 CVD 和癌症死亡风险升高之间存在显著关联的证据。这些发现提示,针对胆石病患者实施有针对性的干预措施,可能降低这些患者的死亡率。